Evidence map›Paper›PMID 38746130›Full record

ArticleResearch square2024

Mapping Novel Frataxin Mitochondrial Networks Through Protein- Protein Interactions.

Etienne Gnimpieba, D M Diing, Jared Ailts, Anja Cucak, Olaksandr Gakh, Grazia Isaya, Seasson Vitiello, Shirley Wang, Paul Pierce, Alec Cooper and 3 more

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Etienne GnimpiebaUniversity of South Dakota.
D M DiingUniversity of South Dakota.
Jared AiltsUniversity of South Dakota Sanford School of Medicine.
Anja CucakSanford Research.
Olaksandr GakhMayo Clinic.
Grazia IsayaMayo Clinic.
Seasson VitielloUniversity of Oklahoma.
Shirley WangUniversity of Oklahoma Health Sciences Center.
Paul PierceUniversity of Oklahoma Health Sciences Center.
Alec CooperUniversity of Oklahoma Health Sciences Center.
Kyle RouxSanford Research.
Lynette K RogersUniversity of Oklahoma Health Sciences Center.
Peter F VitielloUniversity of Oklahoma Health Sciences Center.

Funding

Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI EGLAND, KRISTI A · 2012 to 2020
$20.8M
Transdisciplinary approaches to American Indian and rural population health researchP20GM121341 · NIGMS · SANFORD RESEARCH/USD · PI ANGAL, JYOTI · 2017 to 2022
$11.8M
Hyperoxic Modulation of Thioredoxin SignalingR01HL135112 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI VITIELLO, PETER · 2017 to 2021
$2.0M
NHLBI NIH HHS R01 HL135112NIGMS NIH HHS P20 GM103548NIGMS NIH HHS P20 GM103620NIGMS NIH HHS P20 GM121341
6 · The paper itself

Abstract

Friedreich's Ataxia (FRDA) is a neuromuscular degenerative disorder caused by trinucleotide expansions in the first intron of the frataxin (FXN) gene, resulting in insufficient levels of functional FNX protein. Deficits in FXN involve mitochondrial disruptions including iron-sulfur cluster synthesis and impaired energetics. These studies were to identify unique protein-protein interactions with FXN to better understand its function and design therapeutics. Two complementary approaches were employed, BioID and Co-IP, to identify protein interactions with FXN at the direct binding, indirect binding, and non-proximal levels. Forty-one novel protein interactions were identified by BioID and IP techniques. The FXN protein landscape was further analyzed incorporating both interaction type and functional pathways using a maximum path of 6 proteins with a potential direct interaction between FXN and NFS1. Probing the intersection between FXN-protein landscape and biological pathways associated with FRDA, we identified 41 proteins of interest. Peroxiredoxin 3 (Prdx3) was chosen for further analysis because of its role in mitochondrial oxidative injury. Our data has demonstrated the strengths of employing complementary methods to identify a unique interactome for FXN. Our data provides new insights into FXN function and regulation, a potential direct interaction between FXN and NFS1, and pathway interactions between FXN and Prdx3.

Indexed as

BioID2frataxinFriedreich’s Ataxiamitochondriaperoxiredoxinprotein landscape

Identifiers

PMID38746130
PMCPMC11092868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.